Strategic report Governance report Financial statements 155 Notes to the Financial Statements for the year ended 31 December 2017 1.
Basis of preparation Following the publication of FRS 100 Application of Financial Reporting Requirements by the Financial Reporting Council, the Company adopted FRS 101 Reduced Disclosure Framework as its accounting framework in 2015.
No disclosures previously made in the Companys Financial Statements are omitted on the application of FRS 101.
The separate Financial Statements of the Company are presented as required by the Companies Act.
They have been prepared under the historical cost convention, except for the revaluation of certain financial instruments held at fair values at the end of each reporting period, as explained in the accounting policies.
and in accordance with applicable United Kingdom law and United Kingdom Generally Accepted Accounting Practice.
As discussed on page 35 of the Strategic report, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.
Accordingly, the going concern basis continues to be used in preparing these Financial Statements.
As permitted by FRS 101, the Company has taken advantage of the disclosure exemptions available under that standard in relation to share-based payments, financial instruments, capital management, presentation of comparative information in respect of certain assets, presentation of a cash flow statement and certain related party transactions.
Significant accounting policies The principal accounting policies adopted are the same as those set out in Note 3 to the Consolidated Financial Statements except as noted below.
Investments in subsidiaries are stated at cost less, where appropriate, provisions for impairment.
The Company has share-based payment arrangements involving employees of its subsidiaries.
The cost of these arrangements is measured by reference to the fair value of equity instruments on the date they are granted.
Cost is recognised in investment in subsidiary undertakings and credited to the profit and loss account reserve on a straight-line basis over the vesting period.
Where the cost is subsequently recharged to the subsidiary, it is recognised as a reduction in investment in subsidiary undertakings.
The Company is the sponsor of the Tullett Prebon plc Employee Benefit Trust 2007 and applies the look-through approach to the Trusts assets, liabilities and results which are included as part of the Company.
Profit for the year As permitted in section 408 of the Companies Act 2006 the Company has elected not to present its own profit and loss account for the year.
The auditors remuneration for audit and other services is disclosed in Note 6 to the Consolidated Financial Statements.
The Company has noemployees 2016: nil.
Information about individual Directors is provided in the audited part of the Report onDirectors Remuneration on pages 69 to 89. www.
com 156 Financial statements Notes to the Financial Statements continued for the year ended 31 December 2017 4.
Investment in subsidiary undertakings 2017 2016 m m Cost At 1 January 2,542 1,077 Capital contribution arising on share-based awards 19 21 Increase in investment in subsidiary undertaking 14 161 Acquisition of subsidiary undertaking 20 1,283 At 31 December 2,595 2,542 On 30 December 2016, the Group issued 310.3m shares with a fair value of 1,283m to acquire 100% of the share capital of ICAP Global Broking Holdings Limited ICAP.
No further consideration is payable in respect of the acquisition.
Further information about subsidiaries, including disclosures about non-controlling interests, is provided in the Group Undertakings section of this Annual Report.
Trade and other receivables 2017 2016 m m Non-current receivables Amounts owed by Group undertakings 336 Current receivables Amounts owed by Group undertakings 3 363 Corporation tax 15 Prepayments and accrued income 1 2 19 365 6.
Trade and other payables 2017 2016 m m Accruals and deferred income 7 22 Amounts due to Group undertakings 6 Deferred consideration 8 7 21 29 7.
Other long term payables 2017 2016 m m Deferred consideration 16 TP ICAP Annual Report and Accounts 2017 Strategic report Governance report Financial statements 157 8.
Interest bearing loans and borrowings Less than Greater than one year one year Total m m m 2017 Sterling Notes June 2019 80 80 Sterling Notes January 2024 12 497 509 12 577 589 2016 Bank loan due December 2017 467 467 Sterling Notes June 2019 80 80 467 80 547 Sterling Notes: Due June 2019 In December 2012 80m Sterling Notes, due June 2019, were issued.
The Notes have a coupon of 5.25% paid semi-annually.
At 31 December 2017 their fair value Level 1 was 84m 2016: 84m.
Sterling Notes: Due January 2024 In January 2017 the Group issued 500m unsecured Sterling Notes due January 2024.
The Notes have a fixed coupon of 5.25% paid semi-annually, subject to compliance with the terms of the Notes.
Proceeds were used to repay the 470m bank loan.
At 31 December 2017 their fair value Level 1 was 533m.
Accrued interest at 31 December 2017 amounted to 12m.
Bank loan: Due December 2017 On the completion of the ICAP acquisition the Group drew on its 470m committed bridge financing facility.
The proceeds were used to repay 140m outstanding on the Groups bank credit facility and 330m to repay a loan acquired with the ICAP acquisition.
Facility fees of3m were incurred in 2016.
The carrying amount of the bank loan approximated to its fairvalue.
Bank credit facility The Group has a 250m committed revolving credit facility, the maturity of which has been extended by a year to April 2019.
During 2016, 140m was drawn to repay the Groups Sterling Notes that matured in July 2016.
The amount drawn was repaid from the proceeds of the bank loan.
The facility was undrawn at the end of the year.
Facility fees of 1% are payable on the undrawn balance.
Arrangement fees are amortised over the maturity of the facility.
Allotted, issued and fully paid Ordinary shares of 25p 554,132,671 554,132,671 The movement in the number of shares during the year is shown in Note 27 to the Consolidated Financial Statements.
2017 2016 m m Allotted, issued and fully paid Ordinary shares of 25p 139 139 310,314,296 ordinary shares were issued on 30 December 2016 with a fair value of 1,283m in connection with the acquisition of ICAP.
Descriptions of the merger reserve and own shares, together with the movements in those reserves, are disclosed in Note 28 to the Consolidated FinancialStatements.
